GREY:ATBPF - Post by User
Comment by
Straylighton Jun 29, 2021 1:01pm
148 Views
Post# 33466558
RE:RE:RE:Changeyoubet
RE:RE:RE:Changeyoubet True, its a consideration that I hadn't thought of before. Delaying P3 by a few months doesnt bother me too much (anything planned a year out is likely to experience some amount of delay, I dont consider a few months to be significant but it sounds like others do) but in general I view any delay as a bad thing.
There is a couple reasons they could be delayed and you add one that could be a positive:
Bad: Poor planning/scheduling, FDA is taking more time, other studies are taking longer, etc.
Good: If there is a serious partner or buyout opportunity and they want more control over P3, they may need more time to provide their input so it is run to their specifications.
If there is a big partner or buyout opportunity that would also be a good reason to acceleate on the other fronts with the CRO.
Who knows what the reality is, we will find out down the road of course.